HPV Screening strategies for women with HIV
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have HIV infection, confirmed by a blood test, doctor's records, or HIV medications you're taking
- You must be 25 years old or older
- You must have an intact cervix (not had it surgically removed)
- You cannot have a history of cervical, vulvar, vaginal, anal, or oral cancer
- You cannot have had cervical treatment for a high-grade abnormality in the past year
- You must be willing and able to sign a consent form or have a legal representative do so
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
This study aims to make cervical cancer screening easier and more accessible for women living with HIV. Researchers will test new ways to help women get screened and receive follow-up care at three clinics across the United States.
This study looks at whether testing for HPV (the virus that can lead to cervical cancer) using a urine sample can help with cervical cancer screening. It’s for women living with HIV, who may be at higher risk and need effective, easy screening.
This study looks at HPV infection and the natural balance of bacteria in the vagina in women with HIV. It aims to understand how these factors affect health and may guide future prevention or treatment.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
This trial studies whether letting people collect their own HPV test sample (a private, at-home option) makes cervical cancer screening easier for people with HIV and/or those who are often underserved. If you’ve declined a Pap test or it’s been 6+ months since your last screening, this may offer a more convenient way to check for HPV and cervical cancer risk.
Hear when a new Human Papillomavirus (HPV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.